Saag MS, Gandhi RT, Hoy JF et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society–USA Panel. JAMA 2020 published online October 14. doi:10.1001/jama.2020.17025 Available at: https://jamanetwork.com/journals/jama/fullarticle/2771873
Allavena C, Hant M, Rev D, et al. Antiretroviral exposure and comorbidities in an aging HIV-infected population: the challenge of geriatric patients. PLoS One 2018;13(9): e0203895. https://www.ncbi.nlm.nih.gov/pubmed/30240419
Abrass CK, Appelbaum SJ, Boyd CM, et al. Updated: the HIV and Aging Consensus Project. Recommended treatment strategies for clinicians managing older patients with HIV. https://aahivm-education.org/hiv-age/contents
Swanepoel CR, Atta MG, D’Agati VD et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2018;93:545-59. https://www.ncbi.nlm.nih.gov/pubmed/29398134
Biver E, Calmy A, Aubry-Rozier B et al. Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis. Osteoporos Int 2019;30:1125-35. https://pubmed.ncbi.nlm.nih.gov/30603840/
Brown TT, Hoy J, Borden M, et al. Recommendations for evaluation and management of bone disease in HIV. Clin Infect Dis 2015;60:1242-51. https://www.ncbi.nlm.nih.gov/pubmed/25609682
Drozd DR, Kitahata MM, Althoff KN et al. Increased risk of myocardial infarction in HIV-infected individuals in North America compared with the general population. JAIDS 2017;75:568-76. https://www.ncbi.nlm.nih.gov/pubmed/28520615
Shmakova A, Germini D, Vassetzky Y. HIV-1, HAART and cancer: a complex relationship. Int J Cancer 2020;146:2666-2679.
Reid E, Suneja G, Ambinder RF, et al. Cancer in people living with HIV, version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2018;16:986-1017. https://www.ncbi.nlm.nih.gov/pubmed/30099375
Opportunistic Infections
Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and
treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the
Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medical
Association of the Infectious Diseases Society of America. Last updated July 22, 2021. Available at https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-opportunistic-infection/whats-new-guidelines?view=full
Kuhar DT et al. Updated US Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis; and Update: interim statement regarding potential fetal harm from exposure to dolutegravir (May 23, 2018). https://stacks.cdc.gov/view/cdc/20711
CDC. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other non-occupational exposure to HIV- United States, 2016. April 18, 2016. Update: interim statement regarding potential fetal harm from exposure to dolutegravir (May 23, 2018). https://stacks.cdc.gov/view/cdc/38856
Pre-Exposure Prophylaxis (PrEP)
Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. Published March 2018. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf
Tan DHS, Hull MW, Yoong D, et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ 2017:189:E1448-E1458. http://www.cmaj.ca/content/189/47/E1448
Perinatal Transmission
Panel on Treatment of Pregnant Women with HIV Infection and and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. Last updated February 10, 2021. Available at https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new-guidelines
Abutaleb A, Sherman KE. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient. Hepatol Int 2018;12:500-9. https://www.ncbi.nlm.nih.gov/pubmed/30238230
Leave a Reply